Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.

Wang Y, Chen Z, Chen J, Pan J, Zhang W, Pan Q, Ding H, Lin X, Wen X, Li Y, Meng QH.

Clin Chim Acta. 2013 Jun 5;421:230-5. doi: 10.1016/j.cca.2013.03.013. Epub 2013 Mar 21.

PMID:
23523589
2.

Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.

Lee SH, Park MJ, Choi SI, Lee EJ, Lee SY, In KH.

Medicine (Baltimore). 2017 Jan;96(4):e5975. doi: 10.1097/MD.0000000000005975.

3.

Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.

Huang WW, Tsao SM, Lai CL, Su CC, Tseng CE.

Pathology. 2010 Apr;42(3):224-8. doi: 10.3109/00313021003631320.

PMID:
20350214
4.

Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.

Feng M, Zhu J, Liang L, Zeng N, Wu Y, Wan C, Shen Y, Wen F.

Int J Clin Oncol. 2017 Apr;22(2):283-290. doi: 10.1007/s10147-016-1073-y. Epub 2016 Dec 18.

PMID:
27990560
6.

[Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].

Liu YQ, Zhang HL, Gao WJ, Lan X, Yuan BJ, Zou JM.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2008 Jan;26(1):34-8. Chinese.

PMID:
18302890
7.

Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer.

Sun N, Chen Z, Tan F, Zhang B, Yao R, Zhou C, Li J, Gao Y, Liu Z, Tan X, Zhou F, He MY, Shao K, Li N, Qiu B, Sun J, Yu Y, Wang S, Zhao Y, Shi X, He J.

Clin Cancer Res. 2013 Sep 15;19(18):5136-45. doi: 10.1158/1078-0432.CCR-13-0046.

8.

Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis.

Hung TL, Chen FF, Liu JM, Lai WW, Hsiao AL, Huang WT, Chen HH, Su WC.

Clin Cancer Res. 2003 Jul;9(7):2605-12.

9.

Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.

Tian P, Shen Y, Feng M, Zhu J, Song H, Wan C, Chen L, Wen F.

Postgrad Med. 2015 Jun;127(5):529-34. doi: 10.1080/00325481.2015.1048180. Epub 2015 May 15.

PMID:
25979108
10.

[Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].

Sánchez de Cos Escuín J, López Parra S, Disdier Vicente C, Martín Vicente MJ, Masa Jiménez JF, Domínguez Retortillo C.

An Med Interna. 1996 Aug;13(8):369-73. Spanish.

PMID:
8983362
11.

Diagnostic value of three tumor markers determined in pleural effusions.

Conejo JR, Benedito JE, Jimenez A, Menchen M, Cano J, Granizo V, Larrodera L.

Eur J Clin Chem Clin Biochem. 1996 Feb;34(2):139-42.

PMID:
8833646
12.

Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.

Görgün D, Seçik F, Midilli K, Akkaya V, Yıldız P.

Respir Med. 2013 Aug;107(8):1260-5. doi: 10.1016/j.rmed.2013.04.011. Epub 2013 Jun 18.

13.

Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.

Ma Z, Li H, Wang B, Shen Q, Cui E, Min L, Qian F, Ping J, Dai L.

J Cancer Res Clin Oncol. 2013 Apr;139(4):557-62. doi: 10.1007/s00432-012-1357-1. Epub 2012 Dec 7.

PMID:
23224432
14.

Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.

Lai RS, Chen CC, Lee PC, Lu JY.

Jpn J Clin Oncol. 1999 Sep;29(9):421-4.

PMID:
10563194
15.

WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.

Yang TM, Leu SW, Li JM, Hung MS, Lin CH, Lin YC, Huang TJ, Tsai YH, Yang CT.

J Cancer Res Clin Oncol. 2009 Jul;135(7):919-24. doi: 10.1007/s00432-008-0527-7. Epub 2008 Dec 16.

PMID:
19085002
16.

Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.

Han HS, Yun J, Lim SN, Han JH, Lee KH, Kim ST, Kang MH, Son SM, Lee YM, Choi SY, Yun SJ, Kim WJ, Lee OJ.

Int J Cancer. 2013 Aug 1;133(3):645-52. doi: 10.1002/ijc.28054. Epub 2013 Feb 25.

17.

Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer.

Su WP, Chen YT, Lai WW, Lin CC, Yan JJ, Su WC.

Lung Cancer. 2011 Jan;71(1):28-33. doi: 10.1016/j.lungcan.2010.04.009.

PMID:
20430468
19.
20.

Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.

Sriram KB, Relan V, Clarke BE, Duhig EE, Windsor MN, Matar KS, Naidoo R, Passmore L, McCaul E, Courtney D, Yang IA, Bowman RV, Fong KM.

BMC Cancer. 2012 Sep 25;12:428. doi: 10.1186/1471-2407-12-428.

Supplemental Content

Support Center